We suspect that the difference of tau manifestations is likely due to dopamine modifications and perhaps different amount of tau proteins in each neuron and believe that our tau-PD Drosophila model offers a robust animal model that can facilitate to investigate modification of tau pathogenesis. The gene discussed is MAPT; the disease is Parkinson disease.